FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services home page

FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

horizontal rule

Unified Agenda of Federal Regulatory and Deregulatory Actions
Spring 2002

The Unified Agenda of Federal Regulatory and Deregulatory Actions, (also know as the semi-annual regulatory agenda) is published in the spring and fall of each year. Since 1978, Federal agencies have been required by Executive orders to publish agendas of regulatory and deregulatory activities. The Regulatory Plan, which is published as part of the fall edition of the Agenda, identifies regulatory priorities and contains additional detail about the most important significant regulatory actions that agencies expect to take in the coming year.

Following is the portion of the Spring 2002 Unified Agenda for the Food and Drug Administration.

Food and Drug Administration—Prerule Stage
Sequence Number Title Regulation Identification Number
732 Requirements for Submission of In Vivo Bioequivalence Data0910-AC23

Food and Drug Administration—Proposed Rule Stage
Sequence Number Title Regulation Identification Number
733 Over-the-Counter (OTC) Drug Review0910-AA01
734 Establishment Registration and Product Listing for Drugs and Biologics0910-AA49
735 Investigational New Drugs: Export Requirements for Unapproved New Drug Products0910-AA61
736 Safety Reporting Requirements for Human Drug and Biological Products0910-AA97
737 Blood Initiative0910-AB26
738 Applications for FDA Approval to Market a New Drug; Complete Response Letter; Amendments to Unapproved Applications0910-AB34
739 Current Good Manufacturing Practice for Medicated Feeds0910-AB70
740 Current Good Manufacturing Practice in Manufacturing, Packing, or Holding Dietary Ingredients and Dietary Supplements0910-AB88
741 Requirements for Submission of Labeling for Human Prescription Drugs and Biologics in Electronic Format0910-AB91
742 Requirements Pertaining to Sampling Services and Private Laboratories Used in Connection With Imported Food0910-AB96
743 Status Reports of Distribution and Use Information for Antimicrobial Animal Drug Products Used in Food-Producing Animals0910-AC04
744 Control of Salmonella Enteritidis in Shell Eggs During Production and Retail0910-AC14
745 Institutional Review Boards: Registration Requirements0910-AC17
746 Aluminum in Large- and Small-Volume Parenterals Used in Total Parenteral Nutrition0910-AC18
747 Use of Materials Derived From Bovine and Ovine Animals in FDA-Regulated Products0910-AC19
748 Postmarketing Reports of Substandard or Ineffective Bulk Ingredients and Bulk Ingredients From Unapproved Sources0910-AC20
749 Chronic Wasting Disease: Control of Food Products and Cosmetics Derived From Exposed Animal Populations0910-AC21
750 Exception From General Requirements for Informed Consent; Request for Comments and Information0910-AC25
751 Bar Code Label Requirements for Human Drug Products0910-AC26
752 Medical Devices; Anesthesiology Devices; Proposed Reclassification of Pressure Regulators for Use With Medical Oxygen0910-AC30
753 Medical Devices; Patient Examination and Surgeons' Gloves; Adulteration0910-AC32
754 Amendments to the Performance Standard for Diagnostic X-Ray Systems and Their Major Components0910-AC34

Food and Drug Administration—Final Rule Stage
Sequence Number Title Regulation Identification Number
755 Determination That Informed Consent Is Infeasible or Is Contrary to the Best Interest of Recipients0910-AA89
756 Labeling for Human Prescription Drugs; Revised Format0910-AA94
757 Use of Ozone-Depleting Substances0910-AA99
758 FDA Export Reform and Enhancement Act of 1996; Reporting and Recordkeeping Requirements for Unapproved or Violative Products Imported for Further Processing or Incorporation and Later Export0910-AB24
759 Revisions to the General Safety Requirements for Biological Products; Final Rule0910-AB51
760 Supplements and Other Changes to an Approved Application0910-AB61
761 Food Labeling: Trans Fatty Acids in Nutrition Labeling, Nutrient Content Claims, and Health Claims0910-AB66
762 CGMPs for Blood and Blood Components: Notification of Consignees and Transfusion Recipients Receiving Blood and Blood Components at Increased Risk of Transmitting HCV (Lookback)0910-AB76
763 Antibiotic Resistance Labeling0910-AB78
764 Food Additives: Food Contact Substances Notification System0910-AB94
765 Marking Requirements for and Prohibitions on the Reimportation of Imported Food Products That Have Been Refused Admission into the United States0910-AB95
766 Efficacy Evidence Needed for Products To Be Used Against Toxic Substances When Human Studies Are Unethical0910-AC05
767 Additional Safeguards for Children in Clinical Investigations of FDA Regulated Products0910-AC07
768 Revocation of Conditions for Marketing Digoxin Products for Oral Use0910-AC12
769 Postmarket Surveillance0910-AC31
770 Redacting 510(k) Submissions0910-AC33
771 Section 17 Best Pharmaceuticals for Children Act0910-AC35

Food and Drug Administration—Long-Term Actions
Sequence Number Title Regulation Identification Number
772 Infant Formula: Requirements Pertaining to Good Manufacturing Practice, Quality Control Procedures, Quality Factors, Notification Requirements, and Records and Reports0910-AA04
773 Investigational Use New Animal Drug Regulations (Section 610 Review)0910-AB02
774 Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)0910-AB27
775 Current Good Tissue Practice for Manufacturers of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)0910-AB28
776 Premarket Notice Concerning Bioengineered Foods0910-AC15

Food and Drug Administration—Completed Actions
Sequence Number Title Regulation Identification Number
777 Exports; Notification and Recordkeeping Requirements0910-AB16
778 Foreign Establishment Registration and Listing0910-AB21
779 Amendment of Regulations Regarding Certain Label Statements on Prescription Drugs0910-AB39
780 State Certification of Mammography Facilities0910-AB98
781 Additional Criteria and Procedures for Classifying Over-the-Counter Drugs as Generally Recognized as Safe and Effective and Not Misbranded0910-AC22

Food and Drug Administration—Discontinued Entries
Regulation Identification Number Title Date Withdrawn Comments
0910-AA02 New Animal Drug Approval Process; Implementation of Title I of the Generic Animal Drug and Patent Term Restoration Act (GADPTRA)03/20/2002Withdrawn - Publication is not projected in the next 12 months
0910-AA19 Food Labeling Review03/05/2002Withdrawn
0910-AA20 Medical Foods03/05/2002Withdrawn - Publication is not projected in the next 12 months
0910-AA45 Current Good Manufacturing Practice; Amendment of Certain Requirements for Finished Pharmaceuticals03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AA51 Bioavailability and Bioequivalence Requirements03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AA86 Safety Reporting and Recordkeeping Requirements for Marketed OTC Drugs03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AA90 Direct-to-Consumer Promotion Regulations03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AA98 Current Good Manufacturing Practice; Revision of Certain Labeling Controls03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AB00 Radioactive Drugs for Basic Research03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AB14 Administrative Practices and Procedures; Advisory Opinions and Guidelines03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AB33 Antibiotic Drug Approval and Exclusivity03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AB37 Expanded Access to Investigational Therapies03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AB42 Electronic Submission of Postmarketing Safety Reports03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AB43 Distinguishing Marks for Drug Products Containing Insulin03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AB44 Pregnancy Labeling03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AB49 Supplements and Other Changes to Approved New Animal Drug Applications03/05/2002Withdrawn
0910-AB50 Requirements for Liquid Medicated Feed and Free-Choice Medicated Feed03/05/2002Withdrawn
0910-AB56 Natural Rubber-Containing Drugs; User Labeling03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AB57 Bulk Drug Substances for Use in Pharmacy Compounding03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AB58 Pharmacy and Physician Compounding of Drug Products03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AB59 Drug Products That Present Demonstrable Difficulties for Compounding Because of Reasons of Safety or Effectiveness03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AB60 Discontinuation of a Lifesaving Product03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AB63 Positron Emission Tomography Drugs; Current Good Manufacturing Practice03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AB68 Presubmission Conferences03/05/2002Withdrawn
0910-AB71 Implementation of the Import Tolerance Provisions of the Animal Drug Availability Act of 199603/05/2002Withdrawn
0910-AB72 Mandatory HACCP Regulations for Manufacturers of Rendered Products03/05/2002Withdrawn
0910-AB73 Citizen Petitions; Actions That Can Be Requested by Petition; Denials, Withdrawals, and Referrals for Other Administrative Action03/05/2002Withdrawn - Publication is not projected in the next 12 months
0910-AB74 Surgeon's and Patient Examination Gloves; Reclassification03/13/2002Withdrawn - Publication is not projected in the next 12 months
0910-AB79 Fixed-Combination Prescription and Over-the-Counter Drugs for Human Use03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AB80 180-Day Generic Drug Exclusivity for Abbreviated New Drug Applications03/06/2002Withdrawn
0910-AB81 Repackaging Approval Requirements03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AB82 Stability Testing of Drugs03/06/2002Withdrawn
0910-AB90 Substances Prohibited From Use in Animal Food or Feed03/05/2002Withdrawn
0910-AB92 Fees Relating to Drugs; Waiver and Reduction of Fees03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AB93 Periodic Testing for Certain Human Drug, Veterinary Drug, and Biological Product Final Specifications03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AB99 Medical Devices, Medical Device Establishment Registration and Listing Requirements; Amendment03/13/2002Withdrawn - Publication is not projected in the next 12 months
0910-AC00 Availability for Public Disclosure and Submission to FDA for Public Disclosure of Certain Data and Information Related to Gene Therapy or Xenotransplantation03/05/2002Withdrawn - Publication is not projected in the next 12 months
0910-AC01 Addition to the List of Drug Products That Have Been Withdrawn From the Market for Reasons of Safety or Effectiveness03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AC02 Reporting Information Regarding Falsification of Data03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AC03 Examination of Administrative Record and Other Advisory Committee Records03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AC08 Addition to the List of Drug Products That Have Been Withdrawn or Removed From the Market for Reasons of Safety or Effectiveness03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AC09 Labeling Dietary Supplements for Women Who Are or May Become Pregnant03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AC10 Overwrap for Inhalation Products Packaged in Low Density Polyethylene (LDPE) Containers03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AC11 Implementing Court Decisions, ANDA Approvals, and 180-Day Exclusivity03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AC13 Regulation of Carcinogenic Compounds Used in Food-Producing Animals; Definition of "No Residue"03/20/2002Withdrawn - Publication is not projected in the next 12 months
0910-AC16 Rescission of Substantially Equivalent Decisions and Rescission Appeal Procedures03/05/2002Withdrawn - Publication is not projected in the next 12 months
0910-AC24 Requirements for Medical Gas Containers and Closure Systems03/06/2002Withdrawn - Publication is not projected in the next 12 months
0910-AC27 Promotion and Charging For Investigational Drugs03/06/2002Withdrawn - Publication is not projected in the next 12 months

horizontal rule